LECAP Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,466
Closed -$183K 353
2025
Q4
$183K Buy
+25,466
New +$201K 0.07% 276
2025
Q3
Sell
-21,290
Closed -$206K 361
2025
Q2
$206K Buy
+21,290
New +$220K 0.07% 280
2024
Q4
Sell
-15,565
Closed -$298K 378
2024
Q3
$298K Buy
15,565
+2,934
+23% +$60.8K 0.06% 290
2024
Q2
$261K Sell
12,631
-22,234
-64% -$442K 0.06% 296
2024
Q1
$655K Buy
34,865
+14,092
+68% +$242K 0.14% 236
2023
Q4
$300K Buy
+20,773
New +$283K 0.11% 259

Other funds holding OGN

LECAP Asset Management's OGN Position: Q1 2026 in Review

LECAP Asset Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 25,466 shares — an estimated $183K sold.

LECAP Asset Management first reported a position in OGN in Q4 2023 and held it in 6 quarters. The position peaked at $655K in Q1 2024. 607 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • LECAP Asset Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • LECAP Asset Management sold 25,466 Organon & Co shares in Q1 2026, an estimated $183K.
  • LECAP Asset Management first reported a position in Organon & Co in Q4 2023 and held it in 6 quarters.
  • LECAP Asset Management's Organon & Co position peaked at $655K in Q1 2024.
  • 607 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on LECAP Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.